论文部分内容阅读
世界卫生组织(WHO)统计表明,全世界每年发生结核病800~1000万,约有300万人死于结核病,它是造成死亡人数最多的单一传染病。我国是世界上结核疫情最严重的国家之一。在结核病疫情下降趋势中,结核病流行高峰移至老年,这一特征是全球结核病流行的普遍现象[1]。而对其主要采取抗捞治疗,抗结核药物与其他药物一样,其治疗作用和不良反应构成了药物作用的两重性,并在一定程度上影响化疗工作的顺利进行[2]。如何达到良好的治疗效果,减少药物不良反应的发生是临床医生不断探索的课题,本文对我院2009年1月-2013年6月收治的210例老年肺结核患者的临床资料进行回顾性分析,现报道如下。
According to statistics from the World Health Organization (WHO), there are between 800 and 10 million tuberculosis cases a year in the world and about 3 million people are dying of tuberculosis. It is the single infectious disease that causes the largest number of deaths. Our country is one of the countries with the most serious tuberculosis epidemic in the world. In the declining trend of the tuberculosis epidemic, the peak of the tuberculosis epidemic has shifted to the elderly. This feature is a common phenomenon in the global tuberculosis epidemic [1]. Anti-tuberculosis drugs, like other drugs, are the mainstay of anti-tuberculosis drugs. Their therapeutic effects and adverse reactions constitute the dual nature of drug effects, and to a certain extent affect the smooth progress of chemotherapy [2]. How to achieve a good therapeutic effect and reduce the occurrence of adverse drug reactions are the subject of continuous exploration by clinicians. The clinical data of 210 elderly patients with pulmonary tuberculosis admitted to our hospital from January 2009 to June 2013 are retrospectively analyzed. Reported as follows.